Jon Lykkegaard Andersen
jonla72.bsky.social
Jon Lykkegaard Andersen
@jonla72.bsky.social
MD oncologist. Living with 4 women and a dog.
Reposted by Jon Lykkegaard Andersen
For those of you wondering why newer antibodies are now called -tugs -barts -migs and -ments not -mabs, this is the official @who.int INN explainer

tinyurl.com/49bxfn4t
September 5, 2025 at 3:52 AM
Sune & Nees lod PC’s gamle Randers login blive i skuffen.
#fcklive
bold.dk/fodbold/klub...
FCK søgte hybridspiller: Det lykkedes ikke
FC København undersøgte muligheden for at hente en hybridspiller til offensiven, men ifølge Jacob Neestrup var mulighederne ikke gode nok.
bold.dk
September 2, 2025 at 1:04 PM
Reposted by Jon Lykkegaard Andersen
Vi tager en tur mere #sldk
August 7, 2025 at 8:06 PM
Og så alligevel nogen gange Kent 🤗#fcklive
August 12, 2025 at 7:17 PM
Uha det bliver Skærbæks frue ikke glad for #fcklive
www.tipsbladet.dk/nyhed/superl...
Bombe - Superliga-klub i dialog med Rasmus Falk
Rasmus Falk kan være på vej hjem, skriver TV 2 Fyn.
www.tipsbladet.dk
June 20, 2025 at 2:30 PM
www.theguardian.com/football/202...
Åh nej Thomas Frank til spurs og så ved vi godt hvem Brentford vil spørge😱 #fcklive
Tottenham sack Ange Postecoglou as head coach despite Europa League glory
Ange Postecoglou has been sacked by Tottenham after finishing 17th in the Premier League but winning the Europa League
www.theguardian.com
June 6, 2025 at 4:10 PM
Reposted by Jon Lykkegaard Andersen
The @ascocancer.bsky.social Ed Book is the highest-quality, peer-reviewed, FREE #oncology #MedEd ever. Whether or not you’re at #ASCO25, don’t miss this resource, #OncSky #MedSky, #MedStudentSky! Drop a 📌 in the comments to bookmark the link for later.

ascopubs.org/toc/edbk/cur...

#OncoAlert
May 30, 2025 at 2:39 PM
Reposted by Jon Lykkegaard Andersen
The #ASCO25 #OncoAlertTOP10 Abstracts in #LungCancer 🫁 These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸

@biagioricciutimd.bsky.social
@stephenvliu.bsky.social
@drsanjaypopat.bsky.social
Ping
@drjnaidoo.bsky.social
May 26, 2025 at 10:00 AM
Congrats @barryglendenning.bsky.social and @jonawils.bsky.social. Next season could be grueling, but not today.
May 24, 2025 at 5:26 PM
Reposted by Jon Lykkegaard Andersen
3️⃣ Weeks to go to #ASCO25 !. The schedule can be so overwhelming.. Here is my suggested schedule for thoracic trainees. Start making your schedule in the @asco app today and bring comfortable 👟 @hemoncfellows @hemoncmiami #lcsm
May 12, 2025 at 10:30 AM
Smukt Fro #fcklive
May 4, 2025 at 3:24 PM
Reposted by Jon Lykkegaard Andersen
y’all are wild
March 27, 2025 at 2:40 AM
Reposted by Jon Lykkegaard Andersen
As the ASCO abstracts get reviewed for the June 2025 meeting around now. I wonder what the ISJET coubt will be? 😉 news.cuanschutz.edu/cancer-cente...
When ‘Acceptable’ is Unacceptable: A Call for Objectivity in Cancer Trial Results
CU Cancer Center member D. Ross Camidge, MD, PhD, has been to lots of scientific meetings over the years, and often he doesn’t like what he hears.
news.cuanschutz.edu
March 3, 2025 at 11:00 PM
Reposted by Jon Lykkegaard Andersen
Great day for lung cancer care!. Addition of just 3 cycles of nivolumab immunotherapy to standard neoadjuvant chemo leads to improved overall survival for surgically resectable lung cancer! Just a press release for now but full data upcoming! #lcsm news.bms.com/news/corpora...
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survi...
Bristol Myers Squibb (NYSE: BMY) today announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 study, which evaluated Opdivo ® (nivolumab) in combination with platinum-do...
news.bms.com
February 19, 2025 at 3:31 PM
Reposted by Jon Lykkegaard Andersen
DRs 'Grønlands Hvide Guld' minder om TV2s dokumentar om HPV vaccinen i 2015.

Manipulerende følelsesporno med et sensationelt budskab, der understøttes af tvivlsomme 'eksperter'. Det kan føre til irrationelle beslutninger med irreversibel konsekvenser. #dkmedier
February 12, 2025 at 2:18 PM
Reposted by Jon Lykkegaard Andersen
Perfectly captured.
February 3, 2025 at 2:48 AM
Reposted by Jon Lykkegaard Andersen
The Luka Doncic trade in soccer terms:

If Real Madrid traded Jude Bellingham and Antonio Rüdiger to Barcelona for Frenkie de Jong, a young academy player, and the best U14s player they have—and somehow Sevilla is involved without any clear role in the deal.

#Luka #Doncic #Davis #Mavs #NBA
February 2, 2025 at 9:08 AM
Reposted by Jon Lykkegaard Andersen
Pooled safety data on Sotorasib from 4 studies w combined cohort of 549

Hepatotoxicity 9.9% in those unexposed to immunotherapy vs 24.8% if any prior exposure. 33.3% if given IO within 3months of starting sotorasib

Noteworthy as some trials look at #IO + KRAS combo

#LCSM #oncsky #Medsky #KRAS
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
AbstractIntroduction. We describe the safety of sotorasib monotherapy in patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC) and di
academic.oup.com
January 28, 2025 at 9:13 AM
Reposted by Jon Lykkegaard Andersen
WHO DID THIS!
January 26, 2025 at 6:46 PM
Reposted by Jon Lykkegaard Andersen
Helpful!
January 21, 2025 at 4:30 AM
Reposted by Jon Lykkegaard Andersen
January 20, 2025 at 5:06 PM
Reposted by Jon Lykkegaard Andersen
Amivantamab can be a very nasty drug and would be a harsh reality for newly diagnosed pts.
January 8, 2025 at 4:09 AM